Showing results (21-30 of 451) with videos related to
Sort By:
Pageof 46
Urology|March 4, 2015
Four flawed arguments against prostate-specific antigen screening (and 1 good one)Andrew J VickersTrials|May 18, 2006
Whose data set is it anyway? Sharing raw data from randomized trialsAndrew J VickersPsychosomatic Medicine|July 28, 2005
Analysis of variance is easily misapplied in the analysis of randomized trials: a critique and discussion of alternative statistical approachesAndrew J VickersBMC Medical Research Methodology|November 5, 2005
Parametric versus non-parametric statistics in the analysis of randomized trials with non-normally distributed dataAndrew J VickersJournal of the National Comprehensive Cancer Network : JNCCN|March 15, 2013
Counterpoint: Prostate-specific antigen velocity is not of value for early detection of cancerAndrew J VickersClinical Trials (London, England)|October 4, 2014
Clinical trials in crisis: Four simple methodologic fixesAndrew J VickersEuropean Urology|July 23, 2021
Effects of Magnetic Resonance Imaging Targeting on Overdiagnosis and Overtreatment of Prostate CancerAndrew J VickersThe Spine Journal : Official Journal of the North American Spine Society|March 6, 2021
Decision curve analysis to evaluate the clinical benefit of prediction modelsAndrew J Vickers, Ford HollandControlled Clinical Trials|December 10, 2003
Use of a single global assessment to reduce missing data in a clinical trial with follow-up at one yearAndrew J Vickers, Rob McCarneyNature Reviews. Urology|June 6, 2009
Prostate cancer: estimating the benefits of PSA screeningAndrew J Vickers, Hans LiljaPageof 46